Jounce Therapeutics Inc
(JNCE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | JNCE | SAVA | CSBR | ||
| Company | Jounce Therapeutics Inc | Cassava Sciences Inc | Champions Oncolog | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 1.9200 | 2.03 | 6.55 | ||
| High | 1.9300 | 2.22 | 6.79 | ||
| Low | 1.8800 | 2.02 | 6.12 | ||
| Latest | 1.8800 | 2.18 | 6.12 | ||
| Change | -0.0500 | +0.13 | -0.43 | ||
| % Change | -2.59% | +6.34% | -6.56% | ||
| Volume | 11,600,600 | 959,000 | 13,400 | ||
| 20-Day Average Volume | 1,541,820 | 795,305 | 6,155 | ||
| Previous Close | 1.9300 | 2.05 | 6.55 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 1.9078 | 2.06 | 6.97 | ||
| 20-Day Raw Stochastic | 16.67% | 66.67% | 0.00% | ||
| 20-Day Relative Strength | 62.73 | 48.23 | 40.08 | ||
| Weighted Alpha | -65.90 | +11.85 | -33.38 | ||
| Today's Opinion | 24% Buy | 72% Sell | 40% Sell | ||
| Previous Opinion | 40% Buy | 88% Sell | 32% Sell | ||
| Last Month's Opinion | 24% Buy | 56% Sell | 24% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.59% since 04/26/23 | +10.66% since 02/03/26 | -14.19% since 02/02/26 | ||
| Low | 1.8800 on 05/03/23 | 1.87 on 02/05/26 | 6.12 on 02/10/26 | ||
| High | 1.9500 on 04/28/23 | 2.22 on 02/10/26 | 7.17 on 02/04/26 | ||
| 1-Month | |||||
| %Chg | +1.62% since 04/03/23 | +3.81% since 01/09/26 | -9.73% since 01/09/26 | ||
| Low | 1.8400 on 04/04/23 | 1.87 on 02/05/26 | 6.12 on 02/10/26 | ||
| High | 1.9800 on 04/17/23 | 2.34 on 01/22/26 | 7.71 on 01/28/26 | ||
| 3-Month | |||||
| %Chg | +55.37% since 02/03/23 | -28.05% since 11/10/25 | -9.73% since 11/10/25 | ||
| Low | 0.8957 on 03/10/23 | 1.87 on 02/05/26 | 5.96 on 12/03/25 | ||
| High | 1.9800 on 04/17/23 | 3.45 on 11/26/25 | 8.31 on 12/15/25 | ||
| 6-Month | |||||
| %Chg | -10.48% since 11/03/22 | unch since 08/08/25 | -4.52% since 08/08/25 | ||
| Low | 0.5773 on 12/13/22 | 1.87 on 02/05/26 | 5.96 on 12/03/25 | ||
| High | 2.1180 on 11/09/22 | 4.98 on 10/16/25 | 8.74 on 09/15/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 98,954 | 99,031 | 90,953 | ||
| Shares Outstanding, K | 52,635 | 48,308 | 13,886 | ||
| Annual Sales | 82,000,000 | 0 | 56,940,000 | ||
| Annual Net Income | -50,920,000 | -24,340,000 | 4,700,000 | ||
| Last Quarter Sales | 82,000,000 | 0 | 15,040,000 | ||
| Last Quarter Net Income | 50,960,000 | -10,810,000 | 270,000 | ||
| 60-Month Beta | 0.75 | -0.63 | 0.36 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.60 on 11/10/22 | -0.22 on 11/12/25 | 0.02 on 12/15/25 | ||
| Latest Earnings Date | 05/04/23 | 03/02/26 | 03/10/26 | ||
| Most Recent Dividend | N/A | 0.750 on 12/13/12 | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 38.53 | ||